J CLIN MED 润色咨询

Journal of Clinical Medicine

出版年份:暂无数据 年文章数:15265 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:0.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2022-12-20 Augustkkk 来自福建省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:临床医学
    经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好

    19

    展开19条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2022-07-29 lancet1111

    偏重的研究方向:临床医学
    经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2023-02-09 哈哈大笑VVV 来自四川省

    偏重的研究方向:临床医学
    经验分享:已经七天了,还是pending review。。。

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2021-01-04 高山上的磐石

    垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2024-01-12 mastermaus 来自湖北省

    投稿命中率:5.0
    偏重的研究方向:医学;内科;分子标记
    经验分享:24-01-09投稿,24-01-12被拒,预测模型

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2023-01-11 ms2000001239602400 来自上海

    偏重的研究方向:临床医学
    经验分享:Pending editor decision十天了,不知道多久能有结果。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2022-08-14 Slideaway

    偏重的研究方向:临床医学
    经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2020-09-21 BTSing

    果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2023-04-18 145ea306m02暂无昵称 来自辽宁省

    小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2106840, encodeId=ab59210684065, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床医学<br>经验分享:投稿当天送审,半个月后返回小修的意见,速度快,编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Tue Dec 20 18:11:21 CST 2022, time=2022-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向:临床医学<br>经验分享:投稿第二天有幸under review了,还没有秒拒,希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113705, encodeId=356a2113e05aa, content=偏重的研究方向:临床医学<br>经验分享:已经七天了,还是pending review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8b015529018, createdName=哈哈大笑VVV, createdTime=Thu Feb 09 00:17:25 CST 2023, time=2023-02-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=913516, encodeId=f6819135162b, content=垃圾的杂志,秒拒,晚上投稿,早上醒来就收到 KATE LIU的拒稿信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/17/74839f6bedcf29b61c5e613493a87cbb.jpg, createdBy=62892104603, createdName=高山上的磐石, createdTime=Mon Jan 04 10:23:35 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180977, encodeId=23f121809e751, content=投稿命中率:5.0<br>偏重的研究方向:医学;内科;分子标记<br>经验分享:24-01-09投稿,24-01-12被拒,预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BLo7MYzN0oco8oufpibiaZiaic2nwPWGDsj6pRZzAVnvXic6m050K7ibRdibQgXNm6pFgeChrhQN10zP5nXicHp32QTvGA/132, createdBy=1ef65404738, createdName=mastermaus, createdTime=Fri Jan 12 13:02:30 CST 2024, time=2024-01-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向:临床医学<br>经验分享:Pending editor decision十天了,不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1238557, encodeId=508b123855e8c, content=偏重的研究方向:临床医学<br>经验分享:离谱,14天了还是未处理状态的pending review,根本不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210829/3a5ac19c27b04deba6aeca83d92b2cfb/a897e507ac7046dfa576340be62039ff.jpg, createdBy=d1dc2283557, createdName=Slideaway , createdTime=Sun Aug 14 07:02:40 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887199, encodeId=e24288e199b6, content=果真投稿5天秒杯具 这次换成Lily Pei We are pleased to announce that the Impact Factor of JCM is 3.303 (2019).The journal ranks 36/165 (Q1) under the category "Medicine, General & Internal". 好吧 大家真的避开吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc152112509, createdName=BTSing, createdTime=Mon Sep 21 21:11:35 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126625, encodeId=271d212662552, content=小修后p e n d i n g e d i t or d e c is i o n已经一个月还不给信,真慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63365098092, createdName=145ea306m02暂无昵称, createdTime=Tue Apr 18 06:39:06 CST 2023, time=2023-04-18, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2112370, encodeId=7feb21123e001, content=这个是预警期刊吗现在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4d56414400, createdName=ms4000000565826013, createdTime=Tue Jan 31 13:09:52 CST 2023, time=2023-01-31, status=1, ipAttribution=江苏省)]
    2023-01-31 ms4000000565826013 来自江苏省

    这个是预警期刊吗现在?

    3

    展开3条回复
共161条页码: 1/17页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分